TMCI — Treace Medical Concepts Balance Sheet
0.000.00%
- $406.83m
 - $392.11m
 - $209.36m
 
- 52
 - 37
 - 54
 - 45
 
Annual balance sheet for Treace Medical Concepts, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st  | 2021 December 31st  | 2022 December 31st  | 2023 December 31st  | 2024 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 18.1 | 106 | 81.3 | 123 | 75.7 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 14.5 | 18.6 | 29.2 | 38.1 | 40.8 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 41 | 138 | 133 | 198 | 161 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.829 | 2.85 | 25.5 | 31.6 | 34.4 | 
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 41.8 | 141 | 159 | 252 | 217 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11.6 | 18.2 | 30.2 | 45 | 34.9 | 
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 41 | 47.7 | 98.5 | 114 | 104 | 
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 0.776 | 93.1 | 60.5 | 138 | 113 | 
| Total Liabilities & Shareholders' Equity | 41.8 | 141 | 159 | 252 | 217 | 
| Total Common Shares Outstanding |